To investigate whether immune alterations associated with tumor progression were localized to the primary tumor or reflected systemic changes, peripheral blood from early-stage LUAD patients with different pathological subtypes was pretreated, and the percentage of TERT + leukocytes was analyzed. This evidence concerns the gene TERT and neoplasm.